Plain-English translation of NCT06830473 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study following kidney transplant patients in Scotland to see if certain substances in the urine can predict or identify early transplant rejection. Rather than testing a new medication, researchers will collect urine samples during your routine follow-up visits to look for biomarkers—natural signs in your body that might warn of rejection before serious problems develop. The goal is to help doctors catch transplant problems earlier and improve long-term outcomes.
After a kidney transplant, rejection can happen gradually and silently without early warning signs. If doctors could identify urine biomarkers that signal rejection early, they could intervene sooner and potentially save more transplants from failing.
You likely qualify if…
You likely don't qualify if…
You would continue attending your regular kidney transplant follow-up appointments as usual. During these visits, you will be asked to provide urine samples, which researchers will test for biomarkers that might indicate transplant rejection. The study follows you over time to see how these urine markers relate to your actual transplant health, so you won't need to make extra visits—it fits into your normal clinical care.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United Kingdom
Sponsor
University of Edinburgh
Enrollment target
~200 participants
Started
May 2025
Primary completion
May 2028
Age range
18 Years – 99 Years
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Alexander J Le Saint-Grant, MBChB
University of Edinburgh
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.